From the FDA crackdown on Altria Group Inc.’s JUUL to RH’s recent decision to cut guidance due to a weak housing market outlook, experts can often make smart predictions about […]

Meet the number one seller of both coffee and tea to U.S. restaurants. IPO Edge and the Palm Beach Hedge Fund Association will host a fireside chat with the CEO and CFO […]

Combined Company Expected to be Listed on New York Stock Exchange  Next.e.GO Mobile SE (“e.GO” or the “Company”), the in-production German electric vehicle producer, utilizes disruptive approaches to vehicle design, […]

Clinical Development Business to be a Leading, Pure-Play Contract Research Organization with a Comprehensive Set of Clinical Trial Management, Market Access and Technology Capabilities Labcorp Remains a Leader in the […]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its initial public offering of 2,000,000 […]

By John Jannarone Waldencast Acquisition Corp. (NASDAQ: WALD) has completed its merger with fast-growing skin care brands Obagi Global Holdings Limited and Milk Makeup LLC. The newly-formed company will heretofore […]

MMSB builds upon IndexIQ’s actively managed fixed income suite, pulling from MacKay Shields’ broad fixed income expertise across multiple sectors NEW YORK–(BUSINESS WIRE)–IndexIQ today announced the launch of its newest […]

Transaction Expected to Provide Approximately $279 Million in Cash Proceeds (assuming no redemptions by holders of DHC’s Class A common shares) Which Would Enable GloriFi to Pursue Significant Market Opportunity […]

TORONTO–(BUSINESS WIRE)–Adya Inc. (“Adya” or the “Company”) (TSX: ADYA.V; OTCQB: ADYIF) announces its journey to become a recognizable national holding company. The Company has taken its first major step of […]

– Leading institutional investors commit approximately $235 million through an oversubscribed and upsized private investment in public equity (“PIPE”) led by Frazier Healthcare Partners and Bain Capital Life Sciences – […]